Summary:
«Artificial intelligence is making rapid inroads in helping with the discovery of potential medicines.
In the latest example, a Hong Kong–based biotechnology company, Insilico Medicine, which uses A.I. tools to help it find potential new therapies, announced Tuesday it has brought a drug candidate from an initial scientific hunch to the cusp of human clinical trials in less than 18 months, a time span the company says may be a new record for a process that often takes more than four years.»
Article written by JEREMY KAHN
24|02|2021
Source:
Fortune
https://fortune.com/2021/02/24/insilico-a-i-rare-lung-disease-ipf-record-time/